ĀÜĄņĀŅĀ×

Prof. Schmoll is one the most relevant medical oncologist in Germany, an exceptional leader who influenced the development of oncology. He has educated generations of oncologist in Germany and many other countries and chaired several consensus conferences leading to new treatment guidelines. As editor of the German Standard Refence Book for Medical and Multidisciplinary Oncology, he defined over the last 30 years the treatment standards and education in oncology in German speaking countries.

Prof. Schmoll has been a key clinical researcher who investigated oncology drugs in numerous clinical trials, mostly within the European Organization for Research and Treatment of Cancer (EORTC), Arbeitsgemeinschaft Internistische Onkologie (AIO) and other large international cooperation. His research focused to germ-cell and colorectal cancers, where he defined worldwide standards for the management of patients. His publications have exceptionally high citation rate of eg. 1500-1700/year in 2015, 2016 and 2017 reflecting the international relevance of his research.

Prof Schmoll has established the structures for cooperative and multidisciplinary clinical cancer research in Germany for the past 30 years. He developed 30 cooperative clinical trial groups within the AIO for all tumor types that was the basis for the current acceptance of the AIO as one of the leading trial groups in the word and as the scientific and professional development of the younger generation.

Prof. Schmoll was also instrumental for the European recognition of ā€œMed Oncā€ by forming a ā€œpoliticalā€ coalition to change the voting of Germany in the EU. Within ESMO, he served in the Executive Board, founding chair of the Multidisciplinary Oncology Committee (MOC), and scientific chair of the Istanbul ESMO Congress 2006.